ChitogenX Inc. (CSE: CHGX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
-0.0050 (-25.00%)
Jan 17, 2025, 4:00 PM EST
-83.33%
Market Cap 1.25M
Revenue (ttm) n/a
Net Income (ttm) -1.55M
Shares Out 83.13M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 90,000
Average Volume 509,968
Open 0.0150
Previous Close 0.0200
Day's Range 0.0150 - 0.0150
52-Week Range 0.0050 - 0.1000
Beta -0.75
RSI 49.66
Earnings Date Dec 27, 2024

About ChitogenX

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirk... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol CHGX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.